Endoline

Active

Private limited companyfounded 2023active for 2 yearsGagelveld 29, 2275 Lille, BelgiumKBO/BCE: BE 1002.392.357

Summary

Endoline has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €105,465 and a net result of €73,285. Its solvency ranks better than 49% of 20,330 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

EndolineActiveChecked score 97/100

Risk analysis Report Compare

History

On 17 November 2023, Endoline was incorporated as a private limited company.¹ The company has filed 2 sets of annual accounts, the latest for financial year 2025.²

Acts, filings and financial milestones

All 3Financial 1Filings 2

Next filing, financial year 2026, expected by 31-01-2027

2025

17-12

NBB filing Annual accounts filed

financial year 2025 · micro format

30-06

Financial Equity above €100,000equity €105,465 ▲228%

A profit in every financial year since 2024 builds equity to €105,465.

2024

15-11

NBB filing Annual accounts filed

financial year 2024 · micro format

Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

0 of 1 deed read

About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.